Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
about
Glutamatergic substrates of drug addiction and alcoholismNeurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsThe "stop" and "go" of nicotine dependence: role of GABA and glutamateA Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-StimulationGlutamatergic transmission in drug reward: implications for drug addictionMetabotropic glutamate receptor 3 is associated with heroin dependence but not depression or schizophrenia in a Chinese populationMetabotropic glutamate receptors: from the workbench to the bedside.A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations.Progressive and lasting amplification of accumbal nicotine-seeking neural signalsAssociation between nicotine withdrawal and reward responsiveness in humans and rats.Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline.Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependenceIntracranial self-stimulation to evaluate abuse potential of drugs.Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependenceNeurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.Targeting glutamate homeostasis for potential treatment of nicotine dependence.Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in ratsNew medications for drug addiction hiding in glutamatergic neuroplasticity.Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in ratsDifferential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration.The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task.Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.Influence of Smoking Status and Intensity on Discovery of Blood Pressure Loci Through Gene-Smoking InteractionsPrecipitated withdrawal from nicotine reduces reinforcing effects of a visual stimulus for rats.Nicotine exposure during adolescence alters the rules for prefrontal cortical synaptic plasticity during adulthoodExposure to nicotine and sensitization of nicotine-induced behaviorsNicotine addiction and comorbidity with alcohol abuse and mental illness.Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice.Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function.The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in ratsNicotine exposure during adolescence leads to short- and long-term changes in spike timing-dependent plasticity in rat prefrontal cortex.Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies.N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.Review. Neurobiology of nicotine dependence.Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator.NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala
P2860
Q24648924-2FA9A73A-4C10-44F7-8FD5-8C6C8AEB42FDQ24656267-4D10B9C2-B630-4B33-ADED-750F087F7285Q26824406-DF06AE3F-E073-4E56-9ED6-D3109FD74FEEQ27335497-9F16C6A8-C57A-41B4-B84A-DFEA0036B52CQ28112161-E3C47887-013E-40E2-82F1-59B97DE8E8DDQ28539376-053F51F3-A5A1-4F58-86C5-DA59639AB3DCQ30448778-CAAB20C5-4F34-44A5-AFBD-ED1FD2AF97EBQ30475974-B6EAB177-509A-43D9-9E9A-79824F72F802Q30494110-61457487-8C6F-4E80-A2E4-3B9361605D22Q30625820-B6DBE83E-0640-4F33-A74C-E53E750F067AQ33684431-42CF0131-4EEE-49AC-927E-92388F5C89B1Q33758450-7D22263D-231A-4DDA-9005-AE9782B12E06Q33788180-0FEEBDE0-CBE2-4712-A7C0-116E35F7B1DEQ33845750-8FCF9C18-DBF5-4DBF-970B-310F04B3CC3FQ34009072-3E762EC9-3B58-40E4-B383-BAEA1D23609EQ34012381-AA14576E-9EDB-4610-A8CF-EE01E73A9F48Q34224871-2A9C4FED-430B-456C-87AC-DC2585A7A09FQ34502468-38ED3318-DB57-42A4-83BB-50BBA8FAA810Q34696292-5932A0EA-88E7-4EE4-9A30-B30862ECC1FFQ35154064-561C84E6-848B-4848-9311-86DF37486041Q35291239-17800FEE-E031-47D2-9682-0BB235ABAF81Q35333393-31F3A487-13B2-4226-9EE4-D76A32D765D9Q35647607-6C1B020F-06C9-4513-8546-424BCB189202Q35657336-22AE0E8F-706A-4BF1-BF5F-1FD8AD47B07CQ35740788-90A2316C-AA38-47AF-A5CF-924443DC8D31Q35831006-9674F688-E435-4AFF-9263-A02127B1550BQ35978009-3DFB161F-53C4-4972-90C9-ADF14DBEF26CQ36078496-BC1C6F7B-3BBD-462E-863C-15D35D1D013BQ36135851-68BCD1A1-E48D-4AEA-B5AE-12E5D60A5A51Q36274171-F256E431-940B-4A62-89B5-6910EFC516A9Q36298360-27CEF6D7-6A18-4D66-AE24-0DE7C4C7E26CQ36323545-72D2AD5B-A387-42B4-8D40-225E899A46E4Q36526498-8057327C-05BF-4606-97FC-53471E12F0B4Q36534965-4AB02986-156D-43A0-8B41-5F34F7C01207Q36554456-EC607096-08EE-413D-BB3F-476736C509BAQ36742303-FE47B0DF-0E38-4670-9C95-A9D906C579EAQ36761238-021935DE-EED4-4258-A771-B6323967281BQ37024161-DA106115-63CB-40CB-B97E-EB8DE3A809A0Q37092097-3E811DE1-CC0F-41E8-96C9-FB43D523EB8DQ37125141-F9470B10-F16E-4804-99C4-113547D48828
P2860
Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Group II metabotropic and alph ...... h nicotine withdrawal in rats.
@en
Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate
@nl
type
label
Group II metabotropic and alph ...... h nicotine withdrawal in rats.
@en
Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate
@nl
prefLabel
Group II metabotropic and alph ...... h nicotine withdrawal in rats.
@en
Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate
@nl
P2093
P356
P1476
Group II metabotropic and alph ...... h nicotine withdrawal in rats.
@en
P2093
Athina Markou
Fabrizio Gasparini
Paul J Kenny
P304
P356
10.1124/JPET.103.052027
P407
P577
2003-06-12T00:00:00Z